Presentation is loading. Please wait.

Presentation is loading. Please wait.

Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs Daniel H. Solomon, MD, MPH,

Similar presentations


Presentation on theme: "Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs Daniel H. Solomon, MD, MPH,"— Presentation transcript:

1 Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs Daniel H. Solomon, MD, MPH, Joel M. Kremer, MD, Mark Fisher, MD, Jeffrey R. Curtis, MD, MPH, Victoria Furer, MD, MPH, Leslie R. Harrold, MD, MPH, Marc C. Hochberg, MD, MPH, George Reed, PhD, Peter Tsao, MSc, Jeffrey D. Greenberg, MD, MPH Seminars in Arthritis and Rheumatism Volume 43, Issue 4, Pages 489-497 (February 2014) DOI: 10.1016/j.semarthrit.2013.08.003 Copyright © 2014 Elsevier Inc. Terms and Conditions Terms and Conditions

2 Fig. 1 Seminars in Arthritis and Rheumatism 2014 43, 489-497DOI: (10.1016/j.semarthrit.2013.08.003) Copyright © 2014 Elsevier Inc. Terms and Conditions Terms and Conditions

3 Fig. 2 Seminars in Arthritis and Rheumatism 2014 43, 489-497DOI: (10.1016/j.semarthrit.2013.08.003) Copyright © 2014 Elsevier Inc. Terms and Conditions Terms and Conditions


Download ppt "Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs Daniel H. Solomon, MD, MPH,"

Similar presentations


Ads by Google